Skin Biopsy Testing for Deep Phenotyping Projects at the National Institute of Neurological Diseases and Stroke (NINDS)
ID: 75N95024Q00549Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHBethesda, MD, 20892, US

Original Source

https://sam.gov/opp/949e3b121b784d54980f443558331678/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), intends to award a non-competitive contract for Skin Biopsy Testing as part of its Deep Phenotyping Projects. This procurement aims to analyze small nerve fibers through skin punch biopsies, which is crucial for studying conditions such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Post-Acute Sequelae of COVID-19 (PASC), and Gulf War Illness (GWI). The selected vendor, Johns Hopkins Medicine, will ensure analytic homogeneity across studies by utilizing the same methodologies previously established in past research, thereby maintaining the integrity of the findings. Interested parties may submit capability statements to Cassandra Conley at cassandra.conley@nih.gov by September 9, 2024, at 3:00 PM EST, as the contract is expected to span from October 1, 2024, through September 30, 2027.

    Point(s) of Contact
    Cassandra Conley
    cassandra.conley@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    SOURCES SOUGHT: Long read sequencing services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide long read sequencing services as part of the Global Parkinson’s Genetics Program (GP2). The objective is to genotype over 150,000 individuals worldwide to enhance understanding of genetic risk factors associated with Parkinson’s Disease, requiring the contractor to perform long read sequencing on 500 human genomic DNA samples with a minimum coverage of 25X per sample, alongside ancillary services such as DNA fragmentation, library preparation, and bioinformatics support. Interested parties must submit their capability statements by November 15, 2024, at 9:00 AM Eastern Time, to Rashiid Cummins at rashiid.cummins@nih.gov, ensuring compliance with the specified guidelines and format.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Neurology
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), intends to award a sole source contract for consulting services related to medical device development under the Blueprint MedTech Initiative, focusing on the need for a subject matter expert in neurology. The contract aims to procure specialized consulting services from a board-certified neurologist with experience in treating neurological conditions and expertise in medical device regulation, who will provide strategic guidance and technical oversight to enhance medical device projects within the initiative. This procurement is critical as it supports the development of innovative medical devices aimed at addressing neurological disorders, facilitating the translation of novel technologies from early-stage development to clinical studies. Interested parties may express their interest and capability, but the decision to seek competitive proposals remains at the government's discretion, with all submissions due by November 4, 2024. For further inquiries, contact Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov.
    Clinical Site and Study Monitoring for NIMH Funded Research in Global Settings
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for clinical site and study monitoring services for research funded by the National Institute of Mental Health (NIMH) in global settings. The primary objective of this procurement is to support efforts aimed at reducing mental health disparities, particularly in low and middle-income countries, through rigorous monitoring practices that comply with federal regulations and Good Clinical Practice. This five-year contract, expected to commence on November 25, 2024, has an anticipated budget of up to $2,000,000, with firm-fixed price task orders awarded as needed. Interested parties should direct inquiries to Cassandra Conley at cassandra.conley@nih.gov or Rieka Plugge at rieka.plugge@nih.gov.
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Neurology
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), intends to award a sole source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The primary objective is to procure a highly experienced subject matter expert in neurology who is board-certified and possesses significant experience in medical device regulation, particularly in clinical trials and marketing applications. This consulting role is crucial for advancing neurological medical device technologies and includes responsibilities such as reviewing program operations, advising on project milestones, and mentoring executive teams on regulatory matters. Interested parties may submit capability statements electronically, but the decision to proceed with a non-competitive procurement is at the discretion of the government. For further inquiries, contact Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov.
    Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for scientific management and support services for the National Institute of Mental Health Repository and Genomics Resource (NRGR). The objective of this procurement is to sustain, enhance, and enrich the NRGR, which provides critical biospecimens and genomic data for research on psychiatric disorders, thereby facilitating a deeper understanding of the genetic factors associated with mental health. This initiative is vital for advancing research in the genetics of mental disorders and ensuring broad access to valuable biospecimens and data resources for the scientific community. Proposals are due by November 8, 2024, and must be submitted electronically via the NIH's eCPS system; interested parties should contact Sarah Adan at sarah.adan@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Investment Development
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), intends to award a sole-source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The objective is to procure a subject matter expert with extensive experience in neurotechnology and mental health product development, who will provide strategic guidance and oversight for projects aimed at accelerating the translation of innovative medical devices for neurological disorders. This initiative, established in 2019 with a funding allocation of $32 million, seeks to facilitate the development of groundbreaking technologies and ensure their progression to clinical studies by 2027. Interested parties may submit their qualifications by November 8, 2024, to the designated contacts, Tracy Cain and Llakim Dubroff, at the NIH.
    A--Biomedical Data Computing Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) National Cancer Institute (NCI), is seeking qualified contractors to provide Biomedical Data Computing Support Services. The primary objective of this procurement is to manage and analyze large, complex datasets related to cancer research, supporting the Division of Cancer Epidemiology and Genetics (DCEG) in their ongoing studies both domestically and internationally. This initiative is crucial for enhancing the understanding of cancer causes and prevention through effective data management and analysis, which includes establishing communication infrastructure, managing biomedical data, and providing statistical programming and software development. The NCI anticipates awarding multiple Indefinite Delivery Indefinite Quantity (IDIQ) contracts with an ordering period from September 2025 to September 2035. Interested parties should contact Antoinette C. Robinson at antoinette.robinson@nih.gov or +1 240 276 5823 for further information and are encouraged to monitor www.SAM.gov for updates on the solicitation.